Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Hematemesis in children-Beyond Infancy

9,154 views

Published on

Published in: Health & Medicine

Hematemesis in children-Beyond Infancy

  1. 1. Hematemesis in Children- Beyond Infancy<br />Dr. Divya Nair<br />DNB Pediatrics<br />Mahavir Hospital.<br />
  2. 2. Gastrointestinal (GI) bleeding in children is a fairly common problem<br />In the pediatric ICU population, 6-20% have upper GI bleeds. The incidence of lower GI bleeding has not been well established<br />10-20% of referrals to pediatric gastroenterologists<br />
  3. 3. Upper gastrointestinal (UGI) bleeding originating from esophagus, stomach or duodenum-proximal to the ligament of Treitz (aka duodenojejunal ligament)<br />Commonly presents with hematemesis (vomiting of blood or coffee ground-like material) and/or melena (black, tarry stools)<br />
  4. 4. Etiology:<br />A) Gastrointestinal causes<br />B) Systemic causes<br />C) Genetic causes<br />D) Spurious causes <br />
  5. 5. A) Gastrointestinal causes:<br />1) Esophagitis:<br /> GERD<br />Hiatus Hernia<br /> Infection: e.g. Candida, <br />Aspergillus, CMV, HSV <br />Medications: e.g. tetracycline,<br /> aspirin, NSAIDs, potassium chloride<br />“ erosive esophagitis"<br />
  6. 6. 2) Esophageal Rupture<br /> Mallory-Weiss Syndrome (located at LES)<br />
  7. 7. 3) Gastritis: 
More common than ulcers 
Medications (e.g. NSAIDs, aspirin) 
Infections (e.g., Helicobacter pylori, CMV, <br /> herpes) 
Crohn’s disease<br /> 4) Gastric Erosions:<br />Trauma, burn, shock or sepsis <br />This is usually superficial and occurs mainly in the <br />fundus of the stomach<br />
  8. 8. 5) Peptic Ulcer Disease<br />Zollinger-Ellison syndrome 
Gastrinoma 
Results in multiple <br /> diffuse GI/ small bowel <br /> ulcerations<br />Ulcer with red spot<br />
  9. 9. Bleeding Ulcer<br />
  10. 10. 7)Portal hypertension: 
Esophagealvarices 
Gastricvarices 
Hypertensivegastropathy<br /> Cirrhosis due to congenital <br /> hepatitis, hepatic fibrosis, <br /> cystic fibrosis<br />8) Extra-hepatic portal vein <br /> obstruction<br />Esophagealvarices<br />
  11. 11. 9) Vascular malformations: 
<br />Hemangiomas<br />Aorto-esophageal/-enteric fistulas<br />Dieulafoy ulcer (superficial defect of gastric mucosa which overlies an ectaticsubmucosal a.) <br />Watermelon stomach (gastric antral vascular ectasia) <br />Vasculitiseg: ITP<br />
  12. 12. 10) Tumors: <br />Polyps<br />Lipomas, leiomyoma<br />Adenocarcinoma<br />Lymphoma<br />Metastatic tumors,<br />Kaposi’s sarcoma, Barrett’s esophagus<br />Kasabach-Merritt synd (Hemangioma thrombocytopenia <br /> syndrome) <br />
  13. 13. 11) Traumatic:
Prolapsinggastropathy<br />Foreign body ingestion<br />Direct abdominal trauma<br />Iatrogenic- throat/nose Sx, <br /> traumatic NG<br />
  14. 14. 13) Miscellaneous: <br />Hemobilia<br />Hemosuccuspancreaticus<br />Menetries’ Disease<br />Eosinophilicenteropathy<br />Munchausen by proxy syndrome <br />Barrett’s ulcer secondary to GERD<br />
  15. 15. B) Systemic Causes:<br />Coagulopathy (congenital/acquired): Hemophilia, <br />vWD<br />2) Sepsis, scarlet fever, malaria, leptospirosis<br />3) Burns, Sepsis ( Curling’s ulcer),<br /> Raised ICT, Head injury, Encephalitis ( Cushing’s ulcer)<br />4) HUS, HSP<br />5) Malignancy- Leukemia <br />
  16. 16. 6) Poisonings- chemical, caustic<br />7) Drugs-aspirin, NSAIDS, anti-coagulants<br />8) Food (milk protein) allergy/ hypersensitivity<br />9) Idiopathic<br />NSAID induced Ulcers <br />
  17. 17. C) Genetic conditions:<br />Turner syndrome<br />Ehlers Danlos syndrome<br /> ( cutis hyperelastica)<br />Pseudoxanthomaelasticum<br />KlippelTrenaunay syndrome<br />Osler-Rendu-Weber syndrome<br /> (hereditary hemorrhagic telangectesia) <br />Blue rubber bleb naevus syndrome<br />Hermansky-Pudlak syndrome<br />
  18. 18. D) Spurious causes:<br />I) Hematememis: Bleeding from nose (epistaxis), <br /> mouth, pharynx, <br />hemoptysis<br />II) Malena: Iron preparation, Bismuth, Lead, <br /> spinach, beets, <br /> blueberries<br />
  19. 19. Grading of UGI Bleeds<br />MILD: presents as nausea, vomiting, abdominal discomfort & small <br /> quantity of hematemesis/ malena<br />MODERATE: significant blood loss, tachycardia, cold sweat, hypo-<br /> tension.<br /> No ongoing blood loss; recovers with blood transfusion<br />SEVERE: more striking features of shock present, Hb falls to 8gm% <br /> or less.<br /> Requires multiple blood transfusions d/t ongoing blood loss<br /> Takes longer time to recover; very high mortality unless treated <br /> properly.<br />
  20. 20. Diagnosis:<br />History 
Quantity, frequency, type of blood <br /> (bright red vs coffee ground)<br />Nausea, vomiting, recurrent abdominal pain s/o PUD <br />Dysphagia/ odynophagia, chest pain/burning, <br />hematochezia, melena, bruising, bleeding, repeated retching f/b vomiting of <br /> blood <br />Weight loss, early satiety s/o malignancy<br />Psychiatric symptoms<br />
<br />
  21. 21. Drug ingestion <br />Bleeding sites- skin, mucosa, GUT, joints <br />Recurrent epistaxis<br />H/O Jaundice, stool color<br />Severe and diffuse upper GI ulcerations with chronic diarrhea usually : Zollinger Ellison syndrome or gastrinoma<br />Birth history: lines placed (umbilical lines can result in clotting of portal vein) <br />
  22. 22.  Past history: History of liver disease,<br /> history of pancreatitis, GI surgeries<br /> H/O Bleeding disorders in family 
<br />Medications: NSAID use, aspirin use 
<br /> Diet history: Formula intolerance, food <br /> allergies<br />
  23. 23. Physical examination:<br />Vitals:- Heart rate, respiratory rate, BP, capillary refill, orthostatic changes<br />Pallor<br />During examination of the head, ears, eyes, nose, and throat, look for causes such as: <br />epistaxis, nasal polyps, and oropharyngeal erosions from caustics and other ingestions<br />
  24. 24. Signs of Chronic Liver Disease: Jaundice, Clubbing, leukonychia, palmarerythema, spider nevi, gynecomastia, etc.<br />Vascular malformations: hemangiomas, telangiectasias or purpura over skin<br />Peutz- Jeghers syndrome: pigmented lips, palms, soles<br />Pseudoxanthomaelasticum: “Plucked chicken appearance” of skin<br />
  25. 25. Per Abdomen:<br />Tenderness, Hyperactive bowel sounds<br />Caput medusa with ascites, shrunken liver and <br />splenomegalys/o Cirrhosis with Portal Hypertension<br />Extra-hepatic PHT will have splenomegaly without hepatomegaly<br />Spleen may contract following<br /> a massive bleed and may <br /> not be palpable (Smith<br /> Howard Syndrome)<br />
  26. 26. Work up:<br />CBP, PCV, RBS <br />Coagulation studies <br />LFT to r/o cirrhosis <br />RFT<br />Type and cross-match of several units of blood <br />
  27. 27. Oesophago-gastro-duodenoscopy : If active bleeding, most sensitive and specific for diagnosis and provides therapeutic options<br />Ultrasound with Doppler to assess liver disease and portal hypertension <br />In episodic or obscure bleeding : nuclear medicine radionucleotide studies, arteriography, and wireless video capsule endoscopy are used to assist in identifying the site of blood loss<br />
  28. 28. Special tests:<br />Serum gastrin levels ( Zollinger Ellison syndrome)<br />Peroxide based tests: Gastroccult for upper GI bleed<br />Gastroccult : only test designed specifically for detecting gastric occult blood and determining gastric pH<br />It includes a convenient pH comparison chart for the Clinically relevant range which is important in monitoring antacid prophylaxis<br />Certain ingestions such as red meat, iron, and peroxidase-containing vegetables (eg: turnips, horseradish, broccoli, cauliflower, and cantaloupe), can give false-positive results<br />
  29. 29. Imaging:<br />Barium contrast studies- barium swallows, upper GI series, small bowel <br /> follow-throughs, or barium enemas : for non emergency bleeds, to <br /> point to foreign bodies, ulcers, IBD, or polyps<br />
  30. 30. Endoscopy:<br />Patients with severe upper GI bleeding should receive endoscopy within the first 12 hours of the hemorrhagic episode if they are sufficiently stable, because early endoscopy improves the diagnostic index<br />The site of upper GI bleeding can be identified in 90% of cases when endoscopy is performed within 24 hours<br />This modality is also beneficial in predicting the likelihood of continued bleeding<br />
  31. 31. The Forress classification divides endoscopic findings into the following 3 categories:<br />I - Active hemorrhage (Ia = bright-red bleeding,<br />Ib = slow bleeding)<br />II - Recent hemorrhage (IIa = non-bleeding visible vessel, <br />IIb = adherent clot on base of lesion, <br />IIc = flat pigmented spot)<br />III - No evidence of bleeding<br />
  32. 32. Arteriography : <br /> used to localize lesions when endoscopy has failed <br /> or when the patient cannot cooperate<br /> Detects vascular lesions in esophagus, stomach, <br /> hepatic aneurysms & pseudo-<br /> cysts of pancreas <br /> The modality can be helpful <br /> for bleeding that is distal to <br /> the ligament of Treitz<br />
  33. 33. Management:<br />Initial approach<br />to ensure patient stability, <br />to establish adequate oxygen delivery, <br />to place intravenous access, <br />to initiate fluid and blood resuscitation, <br />to correct any underlying coagulopathies<br />
  34. 34. Children at low risk for recurrent or life-threatening hemorrhage may be suitable for early hospital discharge or even outpatient care<br /> All patients with hemodynamic instability/ active bleeding should be admitted in ICU for resusitation and close observation <br />ICU Requirements:<br /> Pediatric Intensivist, Pediatric Surgeon, Pediatric Gastroenterologist, <br /> Invasive monitors, Ventilators, Attached blood bank, Trained nursing <br /> staff<br />
  35. 35. i) Big bore canula (IV/ IO)<br />Hydration-NS/ RL<br />SOS Transfusion<br />ii) ICU care, invasive monitoring in unstable patients<br />Cardiorespiratory monitor, intake- output chart, <br /> catheterization to monitor UO<br />CVP monitoring helps to guide replacement therapy<br />InjVit K 5mg to be given in case of hepatocellular<br /> failure, cholestatic jaundice.<br />
  36. 36. iii) NG aspiration:<br /> Every ½ to 1 hourly for next 24 hours<br /> If significant blood loss estimated; as it ascertains fresh <br /> blood, decreases aspiration risk and aids in visualization via <br /> endoscope<br /> Gastric lavage with normal saline<br /> Iced saline does not stop bleeding and may even cause <br /> central hypothermia in a small child. <br />
  37. 37. iv) Endoscopic therapy including:<br /> 1. Sclerotherapy (EST): The best Em/El procedure<br /> Acts by producing intimitis thrombosis  fibrosis of <br /> the vessels<br />Sclerosants: Ethanolamine oleate 5%<br /> Sodium morrhuate 5%<br /> Sodium tetradecylsulphate 1.5% <br />Cx: Esophageal ulceration, stricture, Broncho- <br /> esophageal fistula, thoracic duct damage, <br />recurrance of varices, transient bacteremia<br />
  38. 38. 2. Variceal banding: became popular b’cos of Cx of <br /> EST, but it is difficult in children<br /> Elastic band occludes the varix and it is necrosed & <br /> sloughed off in 5-10 days<br />3. Heater probe and bipolar coagulation for ulcers<br />
  39. 39. v) Sengstaken Blakemore tube/ Minnesota tube:<br /> Mechanical Tamponade by balloons which <br /> compresses esophageal & gastric varices<br /> Has 3 lumens- for gastric and esophageal balloons<br /> & for aspiration of gastric contents<br /> Effectively controls acute bleeding, but assosiated<br /> with significant no. of Cx<br /> and rebleeding when tube <br /> is removed<br />
  40. 40. vi) TransjugularIntrahepatic Porto-systemic Shunt (TIPSS):<br />Percutaneous technique that creates a shunt in the <br /> liver between the portal & hepatic veins<br /> Indications: Refractory varicealh’age<br /> Refractory ascites<br />Hepatorenal syndrome<br /> CI: Polycystic liver disease, Right Heart Failure,<br /> Systemic Infections, PV thrombosis, Biliary obstruction, severe hepatic <br /> encephalopathy<br />Cx: Acute thrombosis or Delayed stenosis of shunt, Hepatic <br /> Encephalopathy<br />
  41. 41. vii) Selective embolization<br /> viii) Laparoscopy/ Laparotomy<br />Surgical repair rarely indicated:<br /> 1) Pt with EHPHT is from a remote area without facilities for EST/ <br /> blood transfusions<br /> 2) Pt continues to bleed from ectopic varices/ persistent esophageal <br />varices, despite EST<br /> 3) Hypersplenism<br />Surgeries done for PHT: Decompressive Shunts<br />Devascularization<br /> Liver Transplantation <br />
  42. 42. Pharmacotherapy:<br />ix) Antacids:<br />H2 blockers, Proton pump inhibitors: used as common causes of GI bleed <br /> are gastritis and peptic ulcer disease. <br />Aluminium & Magnesium hydroxide<br />x) Children known to have cirrhosis should receive Antibiotics, <br />prefrebly before endoscopy, as bacterial infections are present <br /> in upto 20% of these patients<br />Treat infections including triple therapy (antibiotics and proton pump <br /> inhibitor) for H. pylori<br />Remove allergen in case of allergy<br />
<br />
  43. 43. xi) Hormones/ hormone analogues (reduces splanchnic blood <br /> flow for variceal bleeding by vasoconstriction) :<br />1) Somatostatin- polypeptide,<br /> inhibits release of vasodialatory GI peptides<br />eg glucagon, VIP & sustance P<br /> Dose: 250microgm IV bolus f/b 250microgm/hr <br /> infusion<br />Disadvn: very short ½ life <br />
  44. 44. 2) Octreotide-synthetic analogue of somatostatin, <br /> much longer ½ life & hence can be given as bolus or <br /> infusion<br /> Dose: 1microgm/kg IV infusion over 30min f/b<br /> 0.5microgm/kg/hour<br />Disadvn: Exorbitant cost<br /> Nausea, flatulence, malabsorbtion (supresses GI <br /> motility & secretion)<br /> Bowel ischemia in high doses <br />
  45. 45. 3) Vasopressin-non peptide, derived from posterior pituitary gland<br />Splanchnic vasoconstriction, constricts lower <br /> esophageal sphincter<br /> Dose: 0.33unit/kg over 20min f/b IV infusion of <br /> 0.33units/kg/hour<br /> S/E: CVS-myocardial ischemia/infarction, VF (can <br /> be decreased by combining it with Nitroglycerine)<br /> Cerebral H’age, Respiratory arrest, <br /> Bowel ischemia & necrosis<br />
  46. 46. 4) Terlipressin (Triglycyl-lysine vasopressin)<br /> Synthetic analogue of vasopressin<br /> Long duration of action & less cardiac S/E<br /> Dose: 2mg IV q6h until bleeding stops f/b 1mg q6h for next <br /> 24hrs<br />5) Miscellaneous Drugs:<br />Clonidine (α2 agonist)<br />Ketanserine & Ritanserine (5HT2 receptor antagonists)<br />Molsidomine (venodialator)<br />
  47. 47. Prophylaxis Against Bleed From Variceal Hemorrhage and Ulceration<br />Primary prophylaxis is indicated because of high rate of <br /> bleeding from esophageal varices and the high mortality <br /> associated with bleeding<br />Prophylactic Propranolol (most commonly used, 1-2mg/<br /> kg) or Nadolol therapy are the only cost-effective ones<br /> No role of prophylactic EST/ EVL<br />
  48. 48. Prophylaxis against stress ulcers are indicated in ICU patients with any of the following charecteristics: <br /> 1) Coagulopathy/ on anti-coagulants <br /> 2) Mechanical ventilation > 2 days <br /> 3) History of GI ulceration/ bleeding withinthe <br /> past year <br /> 4) Two or more of the following risk factors- <br /> sepsis, ICU admission lasting > 1 week, occult <br /> GI bleeding > 6 days, glucocorticoid therapy <br />
  49. 49.  Effective identification and antibiotic treatment of <br />H.Pylori infections is also crucial in preventing <br /> complications including upper GI bleeding <br /> Prevention of NSAID related peptic ulcer disease and <br /> complicating UGI bleed in patients at high risk<br /> In such patients COX-2 selective inhibitor/ non-selective <br /> NSAID + PPI/ Misoprostol is indicated <br />
  50. 50. <ul><li>Patients with history of uncomplicated/ complicated </li></ul> PUD should be tested for H.pylori prior to beginning a <br /> NSAID/ low dose aspirin <br /> If H.pylori present it should be treated with appropriate <br /> therapy, even if it is believed that PU was due to NSAIDs<br />
  51. 51. THANK YOU<br />

×